PROSTATE CANCER WITH A HIGH BASELINE PSA LEVEL AFTER COMBINED TREATMENT
This article describes a rare clinical case of prostate cancer with a high baseline PSA level of 1407 hg/ml. In the course of diagnosis, hormonal and surgical treatment there was a successive dynamics of PSA decline: 07.08.2015–1407 ng/ ml, 14.09.2015–43,61ng/ml; 17.11.2015–0,326 ng/ml; 13.02.2016 (...
Saved in:
Main Authors: | A. T. Asratov, A. S. Kalpinskiy, I. A. Taraki, Yu. V. Samsonov, A. A. Kostin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2017-12-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/228 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Fructose Level and Prostate Specific Antigen (PSA) on Sperms Motility in InFertiled Men
by: Aiesha saadoun jassim, et al.
Published: (2023-01-01) -
Combination of PSA density and MLR improves the diagnostic accuracy of prostate cancer
by: Feng Guo, et al.
Published: (2025-07-01) -
Secondary Analysis of PSA and BCR-Free Survival in Asian Prostate Cancer Patients
by: Gao X, et al.
Published: (2025-06-01) -
THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01) -
A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report
by: Koji Shindo, et al.
Published: (2020-12-01)